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Abstract
Background: Schwann cells (SCs) are the cell type responsible for the formation of the myelin sheath in the peripheral
nervous system (PNS). As retinoic acid (RA) and other retinoids have a profound effect as regulators of the myelination
program, we sought to investigate how their nuclear receptors levels were regulated in this cell type.
Methodology/Principal Findings: In the present study, by using Schwann cells primary cultures from neonatal Wistar rat
pups, as well as myelinating cocultures of Schwann cells with embryonic rat dorsal root ganglion sensory neurons, we have
found that sustained expression of RXR-c depends on the continuous presence of a labile activator, while axonal contact
mimickers produced an increase in RXR-c mRNA and protein levels, increment that could be prevented by RA. The
upregulation by axonal contact mimickers and the transcriptional downregulation by RA were dependent on de novo
protein synthesis and did not involve changes in mRNA stability. On the other hand, RAR-b mRNA levels were only slightly
modulated by axonal contact mimickers, while RA produced a strong transcriptional upregulation that was independent of
de novo protein synthesis without changes in mRNA stability.
Conclusions/Significance: All together, our results show that retinoid receptors are regulated in a complex manner in
Schwann cells, suggesting that they could have a prominent role as regulators of Schwann cell physiology.
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Introduction
All-trans-retinoic acid (RA) and other retinoids are potent
regulators of morphogenesis, cell growth and differentiation,
especially in the nervous system, where their abundance is
comparatively very high [1]. RA induces neurite outgrowth and
neuronal differentiation of several neural cell types, including
embryonic and adult stem cells, dorsal root ganglia neurons
(DRGN), or neuroblastoma cells [2,3,4]. In PC12 cells, RA
inhibits cell proliferation and mimics the effect of neurotrophins on
the expression of several genes, although the retinoid does not
cause neurite extension in parental PC12 cells [5,6,7]. In contrast,
RA can stimulate neuritogenesis in cAMP-dependent protein
kinase A deficient PC12 cell lines that express high levels of RA
receptor [8].
Most of the studies on RA functions on the nervous system
relate to its function as a morphogen during neural tube
development or as a differentiation factor for central nervous
system (CNS) neurons, but RA signaling also occurs in the
peripheral nervous system (PNS). In the sciatic nerve of adult rats,
all the required components of the RA signaling pathway (retinoid
X receptors, RA receptors, RA synthesizing enzymes RALDH-1, -
2 and -3, as well as the cellular retinoid binding proteins CRBP-I,
CRABP-I and -II) are expressed [9]. During regeneration after
nerve crush or transection, local production and activation of RA
in SC is greatly increased [9,10], suggesting a potential role for RA
during PNS development and repair. Moreover, the fact that
retinoid receptors seem to be present on SC [11] suggests that RA
could also play a role in SC physiology during development or in
pathological conditions during Wallerian degeneration and
remyelination, and not only on axonal growth and regeneration.
Furthermore, RA has been shown to exert a variety of functions
on SC, including the induction of neuregulin receptor erbB3 [10],
cooperation with BMP2 to induce GDNF [12], or downregulation
of CNTF expression [13].
On the other hand, RA has been shown to induce differenti-
ation of neuroblastoma cells towards a Schwann cell-resembling
phenotype [14]. It is also a major part of a differentiation cocktail
capable of inducing Schwann cell differentiation from neural stem
cells [15], bone-marrow stromal cells [16], adipose tissue-derived
stem cells [17] or human umbilical cord-derived mesenchymal
stromal cells [18]. Additionally, it has been described that the loss
of RA in zebrafish results in a lack of myelination, although RA
signaling seems to be required at an early stage of nervous system
development, long before the onset of myelin gene expression and
even before the formation of overt glial-specific precursors [19].
More recently, we have been able to show that retinoids
participate in the regulation of peripheral myelin formation [20].
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Both in vitro by using a myelinating DRGN/SC coculture system,
as well as in vivo during the development of the sciatic nerve, RA is
a strong inhibitor of PNS myelin formation through two different
mechanisms, one involving Egr2 (also known as Krox20)
upregulation, which is dependent on retinoid X receptor (RXR)
activation, and another one that implies MAG downregulation
through binding of the retinoid to retinoic acid receptor (RAR).
The members of the nuclear receptor superfamily act as ligand-
dependent transcription factors that regulate the transcription of
the genes that contain specific hormone response elements (HREs)
in their promoters. The retinoids exert their actions through their
binding to two groups of nuclear receptors. All-trans-RA binds with
high affinity to RARs and, with a lower affinity, to RXRs, each
one being codified by three separate genes (-a, -b and -c). Another
retinoid, 9-cis-RA presents a similar affinity in its binding to both
receptors, while the so called rexinoids are able to differentially
activate RXRs. RARs function only as heterodimers with RXRs,
regulating the transcription of the genes that present retinoic acid
response elements (RAREs) in their promoters. Gene regulation by
rexinoids through RXR can be mediated by retinoid X response
elements (RXREs) present in their promoters to which they bind
as RXR-RXR homodimers, as well as by acting as heterodimers of
RXR in combination with several members of the nuclear
receptor superfamily [21].
In addition to the concentration of retinoids and rexinoids, the
ability of a particular cell type to respond to these hormones also
depends on the relative expression levels of the different receptors
present at this particular cell type. The pleiotropic effects of
retinoids in development can partially be explained by the patterns
of expression of the various RAR and RXR genes [22]. Nuclear
receptor expression is under the control of several factors, and,
among others, the retinoids are one of the most important. For
instance, RA is a potent regulator of RAR-b expression in different
cell types, both of neural and non-neural origin [6,23,24,25],
although there are also descriptions of regulation of RAR-a by
estrogen [26], RAR-b and RXR-b by interleukin-1 [27], RAR-b
by nerve growth factor [28], as well as RAR-a and -c by b-
carotene [29].
As SC differentiation is under the control of retinoids, we sought
to investigate if retinoid receptors levels were also regulated in this
cell type during its differentiation, as well as by the retinoid itself.
Using both purified SC cultures, as well as myelinating cocultures
of SCs with sensory DRGNs, we have been able to show that
RXR-c is transcriptionally upregulated by axonal contact, while
RAR-b, as well as RXR-c levels are differentially regulated by RA
in SCs. RA produces a strong upregulation of RAR-b, while
inhibiting RXR-c expression.
Materials and Methods
Ethics Statement
All animal work was done in compliance with the European
Community Law (86/609/EEC) and the Spanish law (R.D. 1201/
2005). All experimental protocols were approved by the Ethics
Committee of the Consejo Superior de Investigaciones Cientificas
(SAF2003-02528; SAF2004-05343; SAF2007-61693).
Rat SC cultures
SCs were isolated and purified as previously indicated [30].
After cytosine arabinoside and Thy-1.1 purification, SCs cultures
were plated in poly-L-Lysine-coated plates and expanded in 10%
heat-inactivated fetal bovine serum (FBS)-containing Dulbecco’s
modified Eagle’s medium (DMEM), in the continuous presence of
2 mM forskolin (Calbiochem) and 60 mg/ml bovine pituitary
extract (BPE; Gibco). Cultures were always used within less than
four passages and all experiments were repeated with SCs from
different preparations. For experiments, freshly seeded SCs were
allowed to attach O.N. in regular media, changed to DMEM
containing 10% of newborn bovine serum (NBS) depleted of
retinoids (achieved by sequential incubations with AG1-X8 resin
and charcoal), in the presence of 2 mM forskolin and 60 mg/ml
BPE. When the effect of BPE and/or forskolin was to be analyzed,
these factors were removed form the cell culture media already at
the time of seeding and the cultures were allowed to adapt to the
new conditions for at least 24 hours before adding the different
treatments. In any case, controls were always treated with an
equivalent amount of vehicle (0.01% ethanol for a typical 1 mM
RA treatment) for the same time. The data depicted in Figure 5 is
a reverse time-course in with all the samples were processed at the
same time, having been treated with the retinoid for the time
indicated in the X-axis. Control cultures were treated with vehicle
(0.01% ethanol) for the longest time point analyzed (48 hours).
Rat DRGN/SC Cocultures
Purified DRGN and SC cultures were prepared by using
methods previously described [30]. In short, neuronal cultures
were established from DRGs obtained from Wistar rat embryos at
15 days of gestation from our animal facility. DRGNs were
dissociated and plated onto collagen coated coverslips or plastic 6-
well plates. Nonneuronal cells were eliminated by cycling (three 2-
day cycles) with a fluorodeoxyuridine-containing medium
(10 mM). Nerve growth factor (NGF)-dependent neurons were
then maintained for 1 week in medium consisting of 10% FBS in
high-glucose minimum essential medium (MEM) and 100 ng/ml
of NGF.
SCs were isolated from the sciatic nerves of 4-day-old rat pups
as previously described [30]. SCs were purified by using cytosine
arabinoside and Thy-1.1 antibody (Sigma) mediated lysis of the
fibroblasts. Approximately 100,000 purified SCs were then seeded
onto 3-weeks-old purified neuronal cultures of <50,000 cells. On
contact with the axons, SCs proliferated rapidly until the axons
were fully populated. When proliferation ceased, SCs began to
elongate and ensheath the axons (premyelination stage). During
this stage, media was progressively changed to media containing
10% NBS depleted of retinoids. At this time (<7 days after
seeding), once the SCs have ceased to proliferate because they
have completely populated the cultures and already have
established a one-to-one relationship with the axons, the cocultures
were induced to myelinate (myelination stage) by the addition of
ascorbic acid (50 mg/ml), which is necessary for the formation of
the basal lamina, an absolute requirement for myelin formation.
This allows us to discriminate between the proliferation/
premyelination stages and the properly called myelination stage.
Treatments with the different retinoids (all at 1 mM unless
otherwise indicated) were initiated at the time of ascorbic acid
addition (considered always as day 0 in all the experiments), and
replenished with every feeding, together with new ascorbic acid,
every 2 to 3 days. Sister control cultures received an equivalent
amount of vehicle (0.01% ethanol for the 1 mM RA treatments).
Western Blot Analysis
Samples were prepared for Western blot analysis by homoge-
nization in radioimmunoprecipitation assay (RIPA) buffer [PBS
with 1% Nonidet P-40/0.5% deoxycholate/0.1% sodium dodecyl
sulfate (SDS)/1 mM PMSF/Complete protease inhibitor tablets
(Roche)] followed by high-speed centrifugation. Protein determi-
nation was made by using the BCATM Protein Assay Kit (Pierce).
Equivalent amounts of total protein extract from each sample were
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electrophoretically separated on 10–15% discontinuous acrylam-
ide gels, transferred to pure nitrocellulose membranes (PRO-
TRAN BA85, Schleicher and Schuell, 0.45 mm), and the equal
loading and transfer of the samples was monitored by Ponceau
staining of the membranes. The different proteins were visualized
by incubation with specific antibodies overnight at 4uC, followed
by incubation with a secondary antibody for two hours at room
temperature. The rabbit polyclonal antibody against RXR-c
(Anaspec) was used at a dilution of 1:1,000. Secondary horseradish
peroxidase (HRP)-conjugated antibodies (Jackson ImmunoRe-
search) were used at a dilution of 1:10,000. The blots were
developed by chemiluminescence (Immun-StarTM HRP Chemi-
luminiscent Kit, Bio-Rad) as indicated by the manufacturer. Blots
were quantitated with the imaging and analysis software ImageJ
1.42d (http://rsbweb.nih.gov/ij/).
Real time quantitative PCR
RNA was extracted using TRIH Reagent (Sigma) and
quantitated with a NanodropTM spectrophotometer (Thermo
Scientific). 1 mg total RNA from each sample was reverse
transcribed with iScript cDNA Synthesis Kit (Bio-Rad) and the
relative levels of the genes of interest determined by quantitative
real time PCR using FastStart Universal SYBR Green Master
(ROX) mix (Roche) in a Mx3005P instrument (Stratagene). Every
measure was always performed in duplicate (two PCR reactions
from the same RT sample) and the average of those technical
replicates was considered as the Ct for that particular sample. All
gene expression levels were normalized to the housekeeping genes
18S rRNA or cyclophilin A.
The primers were designed by using the MacVector suite
(http://www.macvector.com/) coupled with Amplify software
(http://engels.genetics.wisc.edu/amplify/). Primers were designed
from common sequences in the rat and mouse genes and, when
possible (multiexonic genes), spanning two consecutives exons to
avoid interference from possible genomic DNA contamination.
For monoexonic genes, a DNase treatment of the samples was
performed prior to cDNA sysnthesis. In all cases, primers were first
tested by conventional RT-PCR to produce a single amplicon of
the correct size, followed by Q-RT-PCR to avoid primer-dimer
artifacts and ensure a lineal range of quantitation. When several
mRNA splice variants were present for a given gene, the primers
were always designed to recognize all known isoforms. The
primers used are indicated in Supp. Info. Table S1.
Determination of hnRNA
hnRNA levels were also determined by RT-Q-PCR, with the
following differences from regular mRNA determination. The
samples were always treated with DNase to prevent genomic DNA
contamination and reverse transcribed with iScript Select cDNA
Synthesis Kit (Bio-Rad) using specific oligonucleotides for the
genes of interest as primers (the same reverse primer used in the
subsequent PCR). hnRNA levels were determined by using
primers from an exon and a contiguous intron (exon 3 and intron
III for RAR-b and exon 2 and intron II for RXR-c), so DNA
amplification only could occur from newly formed, immature non-
spliced RNA.
Statistical analysis
Throughout the whole article, data shown is representative of at
least two separate experiments performed each time at least in
duplicate (experimental replicates). Significance was determined
by Student’s t-test (unpaired) analysis using StatPlus:mac LE2009
coupled with Microsoft Excel:mac 2008. Unless indicated
otherwise, all comparisons were made against their respective
controls. Throughout the test, differences were considered as
significant when p,0.05. In the Figures, three different levels of
significance (p,0.05; p,0.01 and p,0.005) were considered.
Results
Axonal contact up-regulates RXR-c in SCs
We have recently shown that retinoic acid regulates myelin
formation in the peripheral nervous system. In order to analyze
which receptors were present in SCs, we performed real time RT-
Q-PCR from primary Schwann cell cultures compared to primary
DRG sensory neurons and total brain. In general, with the
exception of RAR-b, all retinoid receptors, RARs and RXRs,
were expressed by isolated Schwann cells at levels comparable or
superior to DRG sensory neurons or total brain, which is known to
express all retinoid receptors at relatively high levels (Fig. 1A).
Interestingly, not all retinoid receptors were homogenously
maintained during the different stages of myelin formation or
Figure 1. RXR-c expression is increased in DRGN/SC cocultures. (A) The mRNA levels of all six RARs and RXRs were analyzed by Q-RT-PCR. The
results are shown as the mean value 6 SD relative to the levels found in whole adult rat brain (dashed line). (B) The mRNA levels of RAR-b and RXR-c
were analyzed by Q-RT-PCR in isolated SCs or myelination-competent DRGN/SC cocultures and compared to isolated DRG neurons and total adult rat
brain. The results are shown as the mean value 6 SEM relative to the levels found in isolated SCs.
doi:10.1371/journal.pone.0017023.g001
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during sciatic nerve development [20]. This is especially notorious
for RXR-c, which was expressed at much higher levels in
myelinating SC/DRGN cocultures than in isolated SCs or sensory
neurons, in which it was present at very low levels (Fig. 1B). For
comparison, RAR-b mRNA levels that were initially higher in
DRGN than in SCs, remained relatively unchanged from DRGN
cultures in myelination-competent SC/DRGN cocultures (Fig. 1B).
These results suggest that cell-to-cell contact upregulates RXR-
c expression, either in the SCs, in the DRGNs or in both cell
types. As SCs express higher levels of retinoid receptors than
DRGNs, and it is well known that neuronal contact strongly
influence its physiology, we decided to analyze whether axonal
contact could upregulate RXR-c expression in SCs. DRGNs are
pseudo-unipolar neurons; they present a bifurcated axon with
central and peripheral branches and no dendrites. Axonal contact
in SCs can be partially mimicked in vitro by the exposition to
cAMP-elevating agents [31] such as the adenylate cyclase activator
forskolin, especially in combination with the neuregulin glial
growth factor (GGF). In order to ascertain whether, effectively,
axonal contact is the responsible for the increased levels of RXR-c
mRNA observed in myelination-competent SC/DRGN cocul-
tures, isolated SCs were treated with forskolin, both in the
presence or absence of a GGF-enriched BPE. Treatment with
either BPE or forskolin produced an increase in RXR-c mRNA
levels with a maximum effect obtained with the combination of
both factors (Fig. 2A). On the other hand, BPE increased the low
basal RAR-b mRNA levels, while forskolin produced a small but
reproducible down-regulation that was even more apparent with
the combination of both factors (Fig. 2B). As expected, myelin-
associated glycoprotein (MAG) mRNA levels and Egr2, two
markers of differentiated SCs, were highly up-regulated by
forskolin, both in the presence or absence of BPE (Fig. 2C–D).
Although forskolin is used frequently to mimic axonal contact, it
also influences Hedgehog (Hg) signaling. As several studies show
cross-regulations during embryonic development between RA and
Hg signaling pathways, we decided to analyze if forskolin
treatment could be able to influence Hg signaling in SC cultures,
which, in turn, might be responsible for changes in RAR-b and
RXR-c expression levels and not the mimicked axonal contact
effect by forskolin. For this purpose, Hh signaling was blocked by
treatment with the specific Hh receptor smoothened inhibitor
cyclopamine, and the RAR-b and RXR-c mRNA levels were
determined. While treatment with forskolin alone produced an
increase in RXR-c and a reduction in RAR-b mRNA levels,
cyclopamine treatment failed to mimic these effects (Fig. 2E–F).
Cyclopamine did not affected RXR-c mRNA levels whilst,
contrary to the effect of forskolin, it did produce a small increase
in RAR-b mRNA levels. In the presence of the smoothened
inhibitor cyclopamine, forskolin was still able to increase RXR-c
mRNA levels and to decrease RAR-b mRNA levels. These results
indicate that the Hh signaling is not involved in the effect of the
axonal mimicker forskolin on SCs.
Next, we analyzed whether de novo protein synthesis was
required for RXR-c induction by axonal contact mimickers.
Interestingly, the presence of the protein synthesis inhibitor
ciycloheximide produced an almost complete suppression of
RXR-c steady state mRNA levels (Fig. 3A), which could not be
reverted by the addition of BPE and forskolin. This result suggests
that SCs express a labile inducer, whose continuous presence is
required for maintenance of RXR-c mRNA levels. On the other
hand, RAR-b mRNA steady-state levels were increased in the
absence of new protein synthesis, while the small reduction
achieved by the combined treatment with BPE and forskolin was
still visible although at a lesser extent (Fig. 3B).
All together, these results suggest that RXR-c and RAR-b
steady-state mRNA levels are maintained in normal conditions
and regulated by axonal contact mimickers throughout different
mechanisms.
Retinoic acid differentially regulates RAR-b and RXR-c
mRNA levels in SCs
The fact that RA can modulate myelin formation in the PNS
[20], together with the multiple descriptions of retinoids being able
to regulate their own receptors levels in several cell types, led us to
clarify whether the same could be true in myelinating Schwann
cell/sensory neurons cocultures.
Retinoic acid treatment produced a tremendous increase in
RAR-b mRNA levels without affecting RAR-a or -c mRNA levels
in myelinating Schwann cell/sensory neurons cocultures (Fig. 4A).
On the other hand, the retinoid produced a small but reproducible
decrease in RXR-a and -b levels, at the same time that RXR-c
mRNA was highly down-regulated. This effect could already be
seen after 4 days of treatment, a time point in which active myelin
formation is taking place, as well as after 10 days of treatment in
which myelin formation in control cocultures has already taken
place almost completely (Fig. 4B).
Although retinoid receptors expression in SCs is generally
higher that in isolated DRG neurons, the later also express them,
so, at this moment, we could not know whether their regulation by
RA in myelinating cocultures is mostly due to the SC component
or if the neuronal levels are also changed. To ascertain if the
variations seen in myelinating cocultures are due to a direct
regulation of their mRNA levels in Schwann cells, we examined if
RA could also regulate retinoid receptors in pure isolated primary
Schwann cells cultures. As observed in myelinating cocultures,
retinoic acid treatment increased RAR-b mRNA levels without
affecting RAR-a and -c levels (Fig. 5). Regarding RXRs, retinoic
acid practically did not change RXR-a and -bmRNA levels, while
RXR-c was highly down-regulated, similarly to what occurred in
myelinating cocultures.
As axonal contact was able to modulate retinoid receptors
levels, and the above experiments depicted in Fig. 5 were
performed with isolated SCs in the continuous presence of the
axonal contact mimickers forskolin and BPE, we next asked
whether RA-regulation of RAR-b and RXR-c in SCs was
dependent on the presence of these factors. As expected, RA
produced a strong up-regulation of RAR-b mRNA levels
irrespective of the presence of forskolin and/or BPE (Fig. 6A).
Unexpectedly, RA downregulation of RXR-c was at least partially
dependent on the presence of the axonal contact mimickers. While
RA was able to inhibit RXR-c in the presence of the axonal
mimickers BPE and forskolin, either alone or in combination, the
retinoid was only able to slightly down-regulate the already
diminished levels found in the absence of axonal mimickers
(Fig. 6B). Analyzing the results from a different perspective, in the
presence of RA, neither BPE nor forskolin, either alone or in
combination, were able to upregulate RXR-c mRNA levels.
RAR-b and RXR-c are regulated by a RAR-dependent
mechanism
As RA actions can be mediated by both RAR and RXR, and
both groups of receptors have been shown to be active during
myelin formation in Schwann cells [20], we asked which receptor(s)
mediate RAR-b and RXR-c regulation. Myelinating cocultures
were treated for seven days with the natural retinoid all-trans-retinoic
acid, which binds to RAR as well as to RXR although with a lower
affinity, as well as with 9-cis-retinoic acid that binds with similar
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affinity to RAR and RXR, or with the pure RAR synthetic agonist
TTNPB that only activates RAR. All three retinoids were equally
able to induce RAR-b and down-regulate RXR-cmRNA levels to a
similar extent, which indicates that binding to RAR is sufficient to
mediate the effect of retinoic acid (Fig. 7A). All three retinoids were
also able to regulate to a similar extent both genes in purified
primary Schwann cell cultures (Fig. 7B), although TTNPB was
more potent, specially regarding RAR-b up-regulation, indicative of
its higher affinity for RAR binding compared to the natural
retinoids [32]. At the low concentration of 1 nM, TTNPB already
produced a statistically significant down-regulation of RXR-c and
upregulation of RAR-b, while 9-cis-RA or all-trans-RA only
produced a small regulation of both receptors that was not
statistically significant. At the more elevated but still physiologically
Figure 2. RXR-c levels in SCs are induced by axonal contact mimickers. (A–D) Isolated SCs were adapted for 24 hours to the absence of the
axonal contact mimickers BPE and forskolin and subsequently treated for 48 hours with 2 mM forskolin (Fk), 60 mg/ml BPE or the combination of both,
and the levels of RXR-c (A), RAR-b (B), MAG (C) and Egr2 (D) were analyzed by Q-RT-PCR. In all instances, the levels reached after the acute combined
treatment were compared to SCs continuously grown in the presence of BPE and Fk (BPE+Fk always). (E–F) SCs were adapted for 24 hours to the
absence the axonal contact mimickers and subsequently treated for 48 hours with 2 mM forskolin (Fk), 5 mM cyclopamine (CPM) or the combination
of both, and the levels of RXR-c (E) and RAR-b (F) were analyzed by Q-RT-PCR. All values are shown as the mean 6 SD relative to their respective
controls (cells grown in the presence of vehicle). Significance was assessed by unpaired Student’s t-test. n.s.: non-significant; *: p,0.05; **: p,0.01;
***: p,0.005.
doi:10.1371/journal.pone.0017023.g002
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relevant dose of 25 nM, all three retinoids were able to significantly
regulate RAR-b and RXR-c gene expression.
RAR-b and RXR-c are regulated at the transcriptional
level
Next, we sought to find whether the regulation of RAR-b and
RXR-c steady-state mRNA levels by RA is due to a transcriptional
mechanism or if, alternatively, other mechanisms such as changes in
mRNA stability were involved. Hetereogeneous nuclear RNAs or
hnRNAs are the precursors of the mature mRNAs still present on the
nucleus of the cell. They present very short half-lives, being processed
as they are exported to the cytoplasm. Measuring their levels
constitutes a good estimation of the transcription rate for a given gene
[33]. In order to ascertain if the transcription rates for RAR-b and
RXR-c were regulated by retinoic acid, myelinating cocultures were
treated with the hormone for 1, 5 or 14 days and the amount of newly
synthesized mRNAs was determined by measuring the hnRNA levels.
Retinoic acid produced a strong increase in RAR-b hnRNA
levels already at day 1 of treatment, an increment that was
maintained, although at a lower level, for the two-weeks time point
analyzed (Fig. 8A). Conversely, RXR-c hnRNA levels were
already reduced after 1-day treatment with the retinoid, reduction
that was maintained and even exacerbated during the whole time
period analyzed. Similarly, in isolated SCs, treatment with the
hormone for 48 h produced an increase in RAR-b hnRNA, whilst
down-regulating RXR-c hnRNA levels (Fig. 8B).
As retinoids can regulate gene expression both directly, through
binding of their receptors to the promoters of their regulated
genes, as well as indirectly, by regulating other transcription
factors which, in turn, are the final mediators of the retinoid
actions, we decided to analyze if RA regulation was dependent on
protein synthesis. While RA was equally able to increase RAR-b
mRNA in SCs both in the presence or absence of the protein
synthesis inhibitor ciycloheximide, the already quite low levels of
RXR-c found in the presence of the inhibitor were not further
down-regulated by RA (Fig. 8C), indicating that the later required
newly synthesized proteins to be effective.
Although these results indicate that both genes are regulated by
a transcriptional mechanism, they do not rule out the possible
existence of an additional layer of regulation at the post-
transcriptional level. To discern this, primary Schwann cells
cultures were pre-treated with retinoic acid for 24 hours, followed
by the addition of the RNA polymerase inhibitor actynomicin D
for different times, and the remaining mRNA levels of RAR-b and
RXR-c were analyzed by real time RT-Q-PCR. Although mRNA
levels were quite different in the presence or absence of retinoic
acid (59-fold higher for RAR-b and 2.5-fold lower for RXR-c),
their half-lives were identical in both circumstances (Fig. 8D),
indicating that RAR-b and RXR-c are regulated by retinoic acid
exclusively at the transcriptional level.
RXR-c protein levels are regulated by retinoids
Finally, we sought to analyze if the changes in RXR-c steady
state mRNAs levels by RA and axonal contact translate into
increased receptor abundance at the protein level. Similarly to
what occurs at the mRNA level, RA treatment of isolated SCs
produced a small decrease in RXR-c protein levels in the absence
of axonal contact mimickers. The combined treatment with BPE
and forskolin produced an increase in RXR-c protein levels, which
was prevented by treatment with the retinoid (Fig. 9).
Discussion
Previous work from our lab and others has shown that retinoids
play an important role during Schwann cell development and
function. The results shown in this work demonstrate that retinoid
receptors are indeed present in Schwann cells and that their
expression levels are tightly regulated by retinoic acid itself as well
as by agents that mimic axonal contact.
It has been described that retinoic acid signaling components
are present in the peripheral nervous system and that after sciatic
nerve injury there is an upregulation in retinoic acid signaling as
measured by a RARE reporter in a transgenic reporter mouse
[10]. This increased RA-signaling is accompanied by a transient
upregulation of RAR-a, -b and -c as well as RXR-a, but not of
RXR-b and -c, in cells morphologically resembling Schwann cells,
although the presence of other cell types (i.e., macrophages) that
also express high retinoid receptors levels, makes this deduction
less conclusive. Similarly, retinoids play an important role during
normal Schwann cell development and function, as regulators of
myelin formation throughout two distinct mechanisms, one RAR-
Figure 3. Protein synthesis inhibition abrogates RXR-c, while increasing RAR-bmRNA steady state mRNA levels. SCs were treated with
the axonal mimickers forskolin and BPE for 24 hours in the presence or absence of 10 mg/ml of the protein synthesis inhibitor cycloheximide (CHX),
and RXR-c (A) and RAR-b (B) mRNA levels were determined by Q-RT-PCR. All values are shown as the mean6 SEM relative to their respective controls
in the absence of cycloheximide.
doi:10.1371/journal.pone.0017023.g003
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dependent that involves MAG down-regulation, and another one
mainly RXR-dependent involving Egr2 upregulation [20]. This
phenomenon is accompanied by the transcriptional regulation of
the final effectors, the retinoid receptors. Especially interesting is
RXR-c, which is highly upregulated in myelination-capable
sensory neuron/Schwann cell cocultures during the phase of
Schwann cell proliferation and migration. Our results suggest that
this increase most probably is dependent on axonal contact and
occurs in the glial component of the coculture, because can be
equally observed in isolated SCs in the absence of sensory neurons
by the combined treatment with forskolin and BPE. Forskolin is an
activator of adenyl cyclase that is a frequent component in
Schwann cell cultures as cAMP is an important secondary
messenger for their growth and maturation that mimics several
of the effects induced by axonal contact [31]. A G-protein coupled
receptor Gpr126 has been recently identified to regulate an in vivo
surge of cAMP in Schwann cells, which allows for Oct 6 activation
at the promyelinating stage [34]. On the other hand, BPE, also
routinely used in Schwann cell cultures, is a supplement rich in
several growth factors such as neuregulins, bFGF and PDGF that
are important for promoting the survival of Schwann cell
precursors [35]. Together with the elevation of cAMP levels
mimicking axonal contact, these growth factors strongly influence
SC physiology and have a synergistic effect on Schwann cell
proliferation [36]. Several studies show cross-regulations during
embryonic development between the RA and Hedgehog signalling
pathway [37] while Desert Hedgehog is also known to be secreted
by SCs and their precursors regulating the formation of the
perineurium and the maintenance of the nerve, including
myelinated fibers [38,39]. Forskolin increases cellular cAMP levels
by direct stimulation of adenylyl cyclase which in turn results in
the activation of protein kinase A (PKA) [40,41]. On the other
hand, activated PKA inhibits Hh signaling [42,43], which opens
the possibility that the observed RAR-b and RXR-c regulation by
forskolin could be dependent on Hh signaling. The fact that
blocking the Hh receptor smoothened by the specific inhibitor
Figure 4. RA upregulates RAR-b and downregulates RXR-c in myelinating cocultures. (A) DRGN/SC cocultures were allowed to myelinate
for 7 days in the presence or absence of 1 mM RA, and the relative levels of RAR-a, -b and -c, as well as RXR-a, -b and -c were determined by Q-RT-PCR.
All values are shown as the mean 6 SD relative to their respective controls (sister cultures treated only with vehicle). (B) Myelinating cocultures were
treated with 1 mM RA from the time of ascorbic acid induction and the levels of all six retinoid receptors were determined by Q-RTR-PCR at different
times of treatment. All values are shown as the mean 6 SD relative to their respective controls (myelinating cocultures treated only with vehicle for
the same length of time).
doi:10.1371/journal.pone.0017023.g004
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cyclopamine was not able to mimic the effect of forskolin, and, in
the case of RAR-b, even modulate its expression in the opposite
direction, indicates that Hh signaling is not participating on the
regulation of RAR-b and RXR-c expression by cAMP.
Schwann cell behavior depends on the combination of extrinsic
growth factors and hormones along with juxtacrine signaling
coming from the neurons. A clear example is the induction of Egr2,
the major myelinogenic transcription factor, whose expression
depends mainly on axonal contact [44,45] but can also be regulated
by extrinsic factors like retinoic acid [20]. Interestingly, Egr2
upregulation by RA is mostly dependent on RXR activation, whose
levels are also upregulated in Schwann cells by axonal contact. It is
tempting to speculate that the same or similar regulatory
mechanisms that control Egr2 expression in Schwann cells could
also be regulating RXR-c expression. Another intriguing possibility
is that Egr2 upregulation by axonal contact could be partially
dependent on RXR-c activation, either by retinoids themselves or
by other agents capable of activating this receptor, like docosahex-
aenoic acid, a long-chain polyunsaturated fatty acid that is highly
enriched in the adult mammalian brain [46] as well as in sciatic
nerve during myelin formation [47] and has been shown to enhance
neurite formation in DRG sensory neurons [48].
On the other hand, retinoids themselves are also potent
regulators of their own receptors in Schwann cells. RAR-b is
Figure 5. RA upregulates RAR-b mRNA and downregulates RXR-c mRNA in isolated SCs. SCs were treated with 1 mM RA for the times
indicated and the relative levels of all six retinoid receptors were determined by Q-RT-PCR. All values are shown as the mean 6 SD relative to their
respective controls.
doi:10.1371/journal.pone.0017023.g005
Figure 6. Influence of axonal contact mimickers on RXR-c and RAR-b regulation by RA. RXR-c downregulation is higher in the presence of
axonal contact mimickers, while RAR-b upregulation was similar irrespective of the growth conditions. Isolated SCs were adapted for 24 hours to the
absence of the axonal contact mimickers BPE and forskolin and subsequently treated for 48 hours with 1 mM RA in the presence or absence of 2 mM
forskolin, 60 mg/ml BPE or the combination of both, and the mRNA levels of RAR-b (A) and RXR-c (B) were analyzed by Q-RT-PCR. In all instances, the
levels reached after the acute combined treatment were compared to SCs continuously grown in the presence of BPE and Fk (BPE+Fk always). All
values are shown as the mean 6 SEM relative to their respective controls.
doi:10.1371/journal.pone.0017023.g006
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highly upregulated by RA in a similar fashion to what has been
described in other cell types, including PC12 cells [6], neuroblas-
toma cells [24], human B- and T-cells [23] or in vivo in neural
crest-derived cells of chick embryos [25]. Presumably, this is a
direct regulation mediated by the RAREs present in the minimal
promoter of this gene [49]. The upregulation of RAR-b by RA is
one of the transcriptional regulations more conserved throughout
evolution and, in fact, even in the amphioxus, the closest living
invertebrate relative of the vertebrates, in which a single RAR
gene (AmphiRAR) exists, retinoic acid is able to induce its
expression in the nerve cord during development [50].
Interestingly, although cAMP has been described to be able to
synergize with the induction of RAR-b by RA in embrionary
carcinoma cells [51], we cannot observe this synergism in
Schwann cells, in which maximum activation by the retinoid
is already achieved in the absence of cAMP activators which, if
any, have a negative impact on RAR-b expression levels, in a
similar manner to what has been described in neuroblastoma
cells [24].
Much less is known about the control of RXR expression levels
by retinoids. The down-regulation of some RXR-c transcripts by
retinoic acid during differentiation of F9 mouse teratocarcinoma
cells has already been described [52], although the mechanisms
involved are quite different from the effect of RA on Schwann
cells. In F9 cells, the effects of the retinoid are not dependent on de
novo protein synthesis, while in Schwann cells, the presence of the
protein synthesis inhibitor cycloheximide not only abolishes RXR-
c regulation but, in fact, it produces a strong decrease in mRNA
levels, uncovering the existence of a labile activator of RXR-c
expression in Schwann cells. Additionally, this de novo protein
synthesis dependence indicates that the effect of the retinoid is not
due to the direct binding of RAR on RXR-c promoter region. In
line with this, no putative RARE can be found in the promoter
sequences upstream of RXR-c rat gene. Unfortunately, neither
the upregulation by axonal contact mimickers nor the downreg-
ulation by RA can be found in promoter assays with constructs
that compass up to 3 Kb upstream of the transcription starting site
of rat RXR-c gene (data not shown).
Figure 7. RAR-b and RXR-c regulation is mediated by RAR. (A) Myelinating cocultures were treated for 7 days with 1 mM of the natural
retinoids all-trans-retinoic acid (RA) and 9-cis-retinoic acid (9-cis), or the synthetic compound TTNPB, and the relative mRNA levels of RAR-b and RXR-c
were determined by RT-Q-PCR. (B) Isolated SCs were treated for 48 hours with different doses of all-trans-retinoic acid (RA), TTNPB or 9-cis-retinoic
acid (9-cis), and the relative levels of RAR-b and RXR-c mRNAs were determined by RT-Q-PCR. All values are shown as the mean 6 SD relative to their
respective controls.
doi:10.1371/journal.pone.0017023.g007
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RXR-c expression is developmentally regulated during periph-
eral nervous system development in rodents [53]. While in chicken
embryos RXR-c is expressed from the onset of neural crest
migration [54], rat RXR-c expression is not detectable in dorsal
root and trigeminal ganglia until 14.5 days post coitum, suggesting
a role for this nuclear receptor in DRGs of late embryos. The in
situ hybridization technique does not allow discrimination on the
nature of the cell types that express RXR-c in the ganglia,
although the same authors already reported a comparatively very
high RXR-c expression level in 7-day-old rats. The detection
onset of RXR-c in these ganglia coincides with the period during
which they begin to innervate their peripheral and central targets.
Interestingly, until 10.5 dpc, Egr2 expression in peripheral nerves
is restricted to the proximities of the ganglia, but at 15.5 there is a
dramatic activation of Egr2 expression being reported along the
whole sciatic nerve [55]. This stage corresponds precisely to the
period of the transition from precursors to embryonic Schwann
cells [56], a transition that involves the activation of Egr2 [44].
Figure 8. Transcriptional regulation of RAR-b and RXR-c by RA. (A) The levels of newly synthesized hnRNA for RAR-b and RXR-c were
determined by RT-Q-PCR in myelinating cocultures treated with 1 mM RA for the indicated times. All values are shown as the mean 6 SD relative to
their respective controls. (B) Newly synthesized RAR-b and RXR-c hnRNA was determined in isolated SCs treated or not with 1 mM RA for 48 hours. All
values are shown as the mean 6 SD relative to their respective controls. (C) SCs were treated with 1 mM RA in combination or not with the axonal
mimickers forskolin and BPE for 24 hours in the presence or absence of 10 mg/ml of the protein synthesis inhibitor cycloheximide (CHX), and RAR-b
and RXR-c mRNA levels were determined by Q-RT-PCR. All values are shown as the mean6 SEM relative to their respective controls in the absence of
cycloheximide and retinoic acid. (D) Isolated SCs were pretreated or not with 1 mM RA for 24 hours and the stability of RAR-b and RXR-c mRNA was
determined by incubating the cells with 10 mg/ml actinomycin D for varying times in the continuous presence or not of the retinoid. All values are
shown as the mean6 SD relative to their respective time zero. RA-treated cells presented RAR-b mRNA levels 59 times higher than control cells, while
RXR-c levels were only 40% of those from control cultures.
doi:10.1371/journal.pone.0017023.g008
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Interestingly, RXR-c signaling has just been shown to be involved
in oligodendrocyte differentiation and to accelerate CNS remye-
lination [57].
RXR belongs to the Class II subfamily of nuclear receptors and,
besides being able to act by itself as a ligand-dependent
transcription factor, its major role is as the heterodimerizing
partner of the Class I subfamily of nuclear receptors, which is
formed by RAR, as well as the vitamin D3 (VDR), the thyroid
hormone (TR) or the peroxisome proliferator activated receptors
(PPAR) [21]. This central role as a required partner in nuclear
receptor signaling implies that the regulation of RXR levels will be
relevant not only for its own signaling, but also for regulating the
ability of SCs to respond to a vast array of hormones, some of
which are likely to play an important role in SC physiology.
Further studies need to be conducted in order to determine
whether RXR-dependent regulation of myelination is mediated by
homodimers or if it is acting just as a heterodimerizing partner for
other nuclear receptors. Regarding this, only RXR-a null-mice are
not viable and show a clear phenotype. In fact, even the triple
compound RXR-a+/2/RXR-b2/2/RXR-c2/2 mutant mice are
viable and almost indistinguishable from RXR-a+/2 mice [58],
suggesting that all three isoforms are basically interchangeable,
making more difficult to study the involvement of RXR on myelin
formation in vivo. Animal models of forced overexpression after
birth, as well as conditional knock-outs of the different RXR
isoforms on Schwann cells should provide further mechanistic
insights into the role of RXRs on Schwann cell differentiation and
subsequent peripheral myelin formation.
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